Table 1.
Utilization of ABPS Tracer Procedures Between 2014 and 2018
| Tracer Procedure | Tracer Utilization |
|---|---|
| Comprehensive module | 42.34% |
| Breast reconstruction | 11.92% |
| Reduction mammaplasty | 21.11% |
| Facial skin malignancy | 6.30% |
| Lower extremity acute trauma | 0.58% |
| Pressure sores | 0.77% |
| Wound management (including burns) | 1.66% |
| Cosmetic module | 40.51% |
| Abdominoplasty | 6.98% |
| Face lift | 2.87% |
| Suction-assisted lipectomy | 2.67% |
| Blepharoplasty | 2.56% |
| Primary augmentation mammaplasty | 24.50% |
| Rhinoplasty | 0.93% |
| Craniomaxillofacial module | 4.82% |
| Cleft palate (primary) | 2.41% |
| Nonsyndromal craniosynostosis | 0.79% |
| Secondary cleft nasal deformity | 0.04% |
| Zygomatic orbital fractures | 0.35% |
| Mandible fractures | 0.51% |
| Unilateral cleft lip repair | 0.72% |
| Hand module | 12.33% |
| Carpal tunnel syndrome | 10.00% |
| Carpometacarpal joint arthroplasty | 0.45% |
| Dupuytrens disease | 0.23% |
| Flexor tendon laceration | 0.55% |
| Metacarpal fracture | 1.09% |